Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences High Content & Phenotypic Screening 2017

Anton Simeonov's Biography



Anton Simeonov, Scientific Director, National Institutes of Health

Anton Simeonov is the scientific director at NCATS. The author or inventor on more than 140 peer-reviewed scientific publications and patents, Simeonov has a truly diverse background, ranging from bioorganic chemistry and molecular biology to clinical diagnostic research and development. He received a Ph.D. in bioorganic chemistry from the University of Southern California and a B.A. in chemistry from Concordia College. Simeonov then trained as a postdoctoral fellow at the Scripps Research Institute under Richard Lerner, M.D., and Kim Janda, Ph.D.

Prior to joining NIH in November 2004, Simeonov was a senior scientist at Caliper Life Sciences, a leading developer of microfluidic technologies, where he was responsible for basic research on novel assay methodologies and development of microfluidic products for research and clinical diagnostics. Simeonov is a literature editor of Assay and Drug Development Technologies and a member of the editorial board of Expert Opinion on Drug Discovery and Drug Target Review.

Anton Simeonov Image

Catalyzing Translation through Improved Processes of Disease and Toxicity Screening

Wednesday, 26 April 2017 at 11:45

Add to Calendar ▼2017-04-26 11:45:002017-04-26 12:45:00Europe/LondonCatalyzing Translation through Improved Processes of Disease and Toxicity ScreeningHigh Content and Phenotypic Screening 2017 in Holiday Inn, Cambridge, UKHoliday Inn, Cambridge, UKSELECTBIOenquiries@selectbiosciences.com

The presentation will provide an overview of novel approaches in disease model-building through collaborative stem cell and 3D tissue bioprinting technology development, construction of screening libraries of approved and investigational agents, and the processes of early-stage drug repurposing.


Add to Calendar ▼2017-04-25 00:00:002017-04-26 00:00:00Europe/LondonHigh Content and Phenotypic Screening 2017High Content and Phenotypic Screening 2017 in Holiday Inn, Cambridge, UKHoliday Inn, Cambridge, UKSELECTBIOenquiries@selectbiosciences.com